Today’s stock pick update – Open Now

Learn More

Learn to Hunt Big Wins LIVE Now

Rob Booker is a big-money trader who has made a career out of hunting the biggest wins. Now, he’s showing other traders how he does it with a formula he calls “Monster Trades.” Go for the biggest wins of your career while controlling your risk, all by learning from Rob. He’s starting a LIVE demonstration soon… (Ad)

Join him here and he’ll start shortly

Lyft Is Officially Suspending Its Ride-Share Service In California

Back above 1 million. The Labor Department reported weekly initial jobless claims for last week rose to 1.106 million, while economists had expected a reading of 923,000. “While there has been a steep decline from crisis peaks, the fact that five months into the crisis initial claims are running at 1.1 million per week is, in absolute terms, very bad news,” said Joshua Shapiro, chief U.S. economist at Maria Fiorini Ramirez, Inc. The renewed increase in claims signals layo...

Read More

Akoustis Technologies Inc (NASDAQ: AKTS): Akoustis shares jumped 11% yesterday after the company introduced the first ultra-sideband 6.5 GHzXBAW filter that covers the entire U-NII-5 to U-NII-8 bands of the new WiFi 6E unlicensed spectrum. Jeff Shealy, Founder and CEO of Akoustis, Read More

What kind of bargain opportunity does CAH offer?

Understanding how some of those relationships work for a company you may have been following for a while can also help identify new opportunities to think about. Over the last couple of years, companies in the Pharmacy industry have become more and more interesting to me, and a more consistent part of my investing method. This week I’ve started to add some of the companies that support the largest players in the industry, and it’s been useful way to increase my understanding of the Pharma...

Read More

Unum Therapeutics Inc., a biopharmaceutical company, focuses on developing a pipeline of novel therapies to treat cancer patients. The company’s novel proprietary technology, known as Bolt-On Chimeric Receptor (BOXR), is designed to improve the functionality of engineered T cells by discovering and incorporating a Â'bolt-on’ transgene into a patients’ engineered T cells to overcome resistance of the solid tumor microenvironment to T cell attack. Its advanced program, PLX94...

Read More

Already subscribed to our premium service?

Click here to Login.

Not a TradersPro subscriber yet?

Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits




This email was sent to phanhoa1821960.trader@blogger.com 
by TradersPro Investiv, LLC
265 N. Main | Ste. D #283
Kaysville | UT | 84037

Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro
 
All trading carries significant risk. Please see our full risk disclaimer.


Disclaimers, Terms & Conditions | Privacy Policy

Copyright © 2020

 

No comments:

Post a Comment